Baird Maintains Outperform on Laboratory Corp, Lowers Price Target to $251
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Eric Coldwell maintains an Outperform rating on Laboratory Corp (NYSE:LH) but lowers the price target from $255 to $251.
July 31, 2023 | 7:59 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Baird analyst maintains Outperform rating on Laboratory Corp but lowers the price target from $255 to $251.
The news is directly about Laboratory Corp (LH). While the Outperform rating is maintained, the lowering of the price target might create some uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100